Hikma Pharmaceuticals PLC ADR (HKMPY)
Company Info
Highlights
$6.40B
$3.22
17.67
2.41
$3.11B
$1.37B
$735.86M
$44.92 - $57.74
Share Price Chart
Loading data...
Compare to other instruments
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Performance
Performance Chart
Loading data...
Returns By Period
Hikma Pharmaceuticals PLC ADR (HKMPY) returned 16.05% year-to-date (YTD) and 20.92% over the past 12 months. Over the past 10 years, HKMPY returned 0.89% annually, underperforming the S&P 500 benchmark at 10.85%.
HKMPY
16.05%
7.44%
18.45%
20.92%
13.18%
0.22%
0.89%
^GSPC (Benchmark)
0.51%
6.15%
-2.00%
12.92%
12.68%
14.19%
10.85%
Monthly Returns
The table below presents the monthly returns of HKMPY, with color gradation from worst to best to easily spot seasonal factors. Returns are adjusted for dividends.
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | Total | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025 | 14.10% | -4.50% | -5.30% | 4.68% | 7.44% | 16.05% | |||||||
| 2024 | 7.85% | 1.16% | -2.71% | 0.42% | 3.08% | -2.72% | 2.31% | 7.86% | -2.46% | -1.65% | -2.18% | 2.07% | 12.96% |
| 2023 | 12.67% | -0.31% | 0.55% | 11.73% | -4.04% | 8.25% | 11.83% | 4.13% | -8.12% | -9.46% | -5.44% | 4.53% | 25.49% |
| 2022 | -7.24% | 0.25% | -1.59% | -12.86% | -9.47% | -8.24% | 7.17% | -26.65% | -0.38% | -5.52% | 25.38% | 3.54% | -36.37% |
| 2021 | -3.55% | -6.12% | 1.57% | 7.58% | 4.36% | -4.15% | 7.44% | -3.28% | -5.95% | 2.24% | -12.75% | 2.56% | -11.51% |
| 2020 | -2.98% | -1.31% | 1.36% | 14.50% | 10.02% | -13.70% | 1.50% | 14.61% | 5.64% | -1.26% | 5.15% | -0.85% | 33.47% |
| 2019 | -7.96% | 11.90% | 3.51% | -3.11% | -9.70% | 9.65% | 3.53% | 9.99% | 1.06% | 1.89% | -3.12% | 6.96% | 24.25% |
| 2018 | -7.89% | -13.67% | 42.80% | 1.53% | 4.29% | 11.01% | 1.08% | 26.08% | -1.47% | -8.57% | 1.14% | -4.99% | 47.25% |
| 2017 | 7.65% | 13.18% | -2.11% | -1.93% | -9.77% | -10.30% | -10.26% | -10.74% | -4.79% | -1.90% | -6.20% | 5.64% | -29.83% |
| 2016 | -19.60% | 3.13% | -0.88% | 13.44% | 3.99% | -5.82% | 9.23% | -12.20% | 0.00% | -22.87% | -8.13% | 4.01% | -35.45% |
| 2015 | 17.88% | 6.96% | -17.26% | 4.45% | -2.33% | -7.33% | 26.45% | -1.82% | -8.04% | -4.29% | 4.84% | 12.96% | |
| 2014 | 20.82% | 15.72% | -5.30% | 5.12% | 4.15% | 5.86% | -5.57% | -1.66% | 5.71% | 0.02% | 2.06% | 53.74% |
Risk-Adjusted Performance
Risk-Adjusted Performance Rank
The current rank of HKMPY is 71, indicating average performance compared to other stocks on our website. Here’s a breakdown of how it compares using common performance measures.
Risk-Adjusted Performance Indicators
The charts below present risk-adjusted performance metrics for Hikma Pharmaceuticals PLC ADR (HKMPY) and compare them to a chosen benchmark (^GSPC). These indicators evaluate an investment's returns against its associated risks.
Loading data...
Dividends
Dividend History
Hikma Pharmaceuticals PLC ADR provided a 2.81% dividend yield over the last twelve months, with an annual payout of $1.60 per share. The company has been increasing its dividends for 13 consecutive years.
| Period | TTM | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Dividend | $1.60 | $1.58 | $1.24 | $1.10 | $1.04 | $0.92 | $0.80 | $0.70 | $0.66 | $0.64 | $0.64 | $0.48 |
Dividend yield | 2.81% | 3.17% | 2.72% | 2.95% | 1.73% | 1.33% | 1.52% | 1.62% | 2.21% | 1.48% | 0.94% | 0.79% |
Monthly Dividends
The table displays the monthly dividend distributions for Hikma Pharmaceuticals PLC ADR. The dividends shown in the table have been adjusted to account for any splits that may have occurred.
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | Total | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025 | $0.00 | $0.00 | $0.96 | $0.00 | $0.00 | $0.96 | |||||||
| 2024 | $0.00 | $0.00 | $0.94 | $0.00 | $0.00 | $0.00 | $0.00 | $0.64 | $0.00 | $0.00 | $0.00 | $0.00 | $1.58 |
| 2023 | $0.00 | $0.00 | $0.74 | $0.00 | $0.00 | $0.00 | $0.00 | $0.50 | $0.00 | $0.00 | $0.00 | $0.00 | $1.24 |
| 2022 | $0.00 | $0.00 | $0.72 | $0.00 | $0.00 | $0.00 | $0.00 | $0.38 | $0.00 | $0.00 | $0.00 | $0.00 | $1.10 |
| 2021 | $0.00 | $0.00 | $0.68 | $0.00 | $0.00 | $0.00 | $0.00 | $0.36 | $0.00 | $0.00 | $0.00 | $0.00 | $1.04 |
| 2020 | $0.00 | $0.00 | $0.60 | $0.00 | $0.00 | $0.00 | $0.00 | $0.32 | $0.00 | $0.00 | $0.00 | $0.00 | $0.92 |
| 2019 | $0.00 | $0.00 | $0.00 | $0.52 | $0.00 | $0.00 | $0.00 | $0.28 | $0.00 | $0.00 | $0.00 | $0.00 | $0.80 |
| 2018 | $0.00 | $0.00 | $0.00 | $0.46 | $0.00 | $0.00 | $0.00 | $0.24 | $0.00 | $0.00 | $0.00 | $0.00 | $0.70 |
| 2017 | $0.00 | $0.00 | $0.00 | $0.44 | $0.00 | $0.00 | $0.00 | $0.22 | $0.00 | $0.00 | $0.00 | $0.00 | $0.66 |
| 2016 | $0.00 | $0.00 | $0.00 | $0.42 | $0.00 | $0.00 | $0.00 | $0.00 | $0.22 | $0.00 | $0.00 | $0.00 | $0.64 |
| 2015 | $0.00 | $0.00 | $0.00 | $0.42 | $0.00 | $0.00 | $0.00 | $0.22 | $0.00 | $0.00 | $0.00 | $0.64 | |
| 2014 | $0.26 | $0.00 | $0.00 | $0.00 | $0.00 | $0.22 | $0.00 | $0.00 | $0.00 | $0.48 |
Dividend Yield & Payout
Dividend Yield
Hikma Pharmaceuticals PLC ADR has a dividend yield of 2.81%, which is quite average when compared to the overall market.
Payout Ratio
Hikma Pharmaceuticals PLC ADR has a payout ratio of 49.07%, which is quite average when compared to the overall market. This suggests that Hikma Pharmaceuticals PLC ADR strikes a balance between reinvesting profits for growth and paying dividends to shareholders.
Drawdowns
Drawdowns Chart
The Drawdowns chart displays portfolio losses from any high point along the way. Drawdowns are calculated considering price movements and all distributions paid, if any.
Loading data...
Worst Drawdowns
The table below displays the maximum drawdowns of the Hikma Pharmaceuticals PLC ADR. A maximum drawdown is a measure of risk, indicating the largest reduction in portfolio value due to a series of losing trades.
The maximum drawdown for the Hikma Pharmaceuticals PLC ADR was 68.91%, occurring on Feb 28, 2018. Recovery took 192 trading sessions.
The current Hikma Pharmaceuticals PLC ADR drawdown is 14.94%.
Depth | Start | To Bottom | Bottom | To Recover | End | Total |
|---|---|---|---|---|---|---|
| -68.91% | Feb 27, 2015 | 130 | Feb 28, 2018 | 192 | Jan 6, 2021 | 322 |
| -63.85% | Aug 5, 2021 | 270 | Sep 26, 2022 | — | — | — |
| -34.97% | Jun 10, 2011 | 12 | Sep 15, 2011 | 41 | Mar 1, 2013 | 53 |
| -16.74% | Jan 11, 2021 | 23 | Mar 5, 2021 | 42 | Jul 12, 2021 | 65 |
| -14.25% | Jul 25, 2014 | 11 | Sep 19, 2014 | 11 | Dec 8, 2014 | 22 |
Volatility
Volatility Chart
The chart below shows the rolling one-month volatility.
Loading data...
Financials
Financial Performance
The chart below illustrates the trends in the financial health of Hikma Pharmaceuticals PLC ADR over time, highlighting three key metrics: Total Revenue, Earnings Before Interest and Taxes (EBIT), and Net Income.
Earnings Per Share
The chart presents the Earnings Per Share (EPS) performance of Hikma Pharmaceuticals PLC ADR, comparing actual results with analytics estimates.
Valuation
The Valuation section provides an overview of how Hikma Pharmaceuticals PLC ADR is priced in the market compared to other companies in the Drug Manufacturers - Specialty & Generic industry. It includes key financial ratios that help investors assess whether the stock is undervalued or overvalued.
PE Ratio
The chart displays the Price-to-Earnings (P/E) ratio for HKMPY, comparing it with other companies in the Drug Manufacturers - Specialty & Generic industry. Currently, HKMPY has a P/E ratio of 17.7. This P/E ratio is in line with the industry average, suggesting the stock may be fairly valued relative to its earnings.
PEG Ratio
The chart shows the Price/Earnings to Growth (PEG) ratio for HKMPY compared to other companies in the Drug Manufacturers - Specialty & Generic industry. HKMPY currently has a PEG ratio of 2.4. This PEG ratio is close to the industry average, suggesting the stock’s valuation is balanced against its growth outlook.
PS Ratio
This chart shows the Price-to-Sales (P/S) ratio for HKMPY relative to other companies in the Drug Manufacturers - Specialty & Generic industry. Currently, HKMPY has a P/S ratio of 2.0. This P/S ratio falls within the average range for the industry, suggesting the stock is fairly valued based on its revenue.
PB Ratio
The chart illustrates the Price-to-Book (P/B) ratio for HKMPY in comparison with other companies in the Drug Manufacturers - Specialty & Generic industry. Currently, HKMPY has a P/B value of 2.7. This P/B ratio is in line with the industry average, suggesting the stock is valued fairly in relation to its book value.
Income Statement
| TTM | |
|---|---|
Revenue | — |
Total Revenue | — |
Cost Of Revenue | — |
Gross Profit | — |
Operating Expenses | — |
Selling, General & Admin Expenses | — |
R&D Expenses | — |
Depreciation And Amortization | — |
Total Operating Expenses | — |
Income | — |
Income Before Tax | — |
Operating Income | — |
EBITDA | — |
EBIT | — |
Earnings From Continuing Operations | — |
Net Income | — |
Income Tax Expense | — |
Other Non-Operating Income (Expenses) | — |
Extraordinary Items | — |
Discontinued Operations | — |
Effect Of Accounting Charges | — |
Non Recurring | — |
Minority Interest | — |
Other Items | — |
Interest Income | — |
Interest Expense | — |
Net Interest Income | — |